Latest KFF Health News Stories
Nueva droga contra la leucemia ofrece esperanza, pero a un costo millonario
El tratamiento con una nueva droga del laboratorio Novartis para casos en los que ha fracasado la quimioterapia o el trasplante de médula costaría $649,000.
‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
Medicare Unveils ‘Skeletal’ Site For Hospice Comparison Shopping
This is the first federal website designed to help families choose a hospice, but experts aren’t impressed.
Las voces olvidadas en el debate de salud: 8 mujeres cuentan sus historias
Los proyectos de salud que se han estado discutiendo dejan de lado muchos de los servicios esenciales para las mujeres, como el cuidado materno y los métodos anticonceptivos.
Often Missing In The Health Care Debate: Women’s Voices
When leaders in Washington discuss the future of American health care, women are not always in the room. Here, nine women share their personal stories, fears and hopes.
Más médicos apoyan un sistema de salud universal
Una nueva encuesta revela que cada vez más los profesionales de la salud se inclinan a un sistema con un pagador único que se haga cargo de las cuentas médicas.
Doctors Warm To Single-Payer Health Care
Growing numbers of physicians say they support a single-payer health care system, a 180-degree turn in opinion over a decade.
Climbing Cost Of Decades-Old Drugs Threatens To Break Medicaid Bank
Medicaid spent billions more in 2016 than the year before on decades-old prescription drugs, including many generics, a Kaiser Health News data analysis shows.
Readers Have Their Say … On Pain And Who Stands To Gain In Drug Market
Kaiser Health News gives readers a chance to respond, react and comment on our stories.
Hospitals Slashed Use Of Two Heart Drugs After Huge Price Hikes
Hospital use of two popular heart medicines, nitroprusside and isoproterenol, dramatically dropped after the prices for both soared.
Taking A U-Turn On Benefits, Big Employers Vow To Continue Offering Health Insurance
Three years ago, only about a quarter of the nation’s large employers were very confident they would have a health plan in 10 years. That number has now risen to 65 percent.
Apoyo bipartidista a programa que ayuda a personas con VIH a tener vivienda
El programa otorgará $320 millones a zonas en las que el virus sigue expandiéndose. Tener un hogar seguro ayuda a llevar adelante un buen tratamiento.
Why One Insurer’s Collapse Could Whack Insurers, Policyholders Across the Country
Little-known rules require all health insurance companies to help pay claims when any one of them fails. Penn Treaty failed big — and insurers around the country are likely to pass those costs onto policyholders.
Congress Revamps Housing Program To Benefit Areas Where HIV Is Spreading
The small federal program once based funding on an area’s cumulative number of cases. It will now be more responsive to places where new outbreaks are occurring.
Cuando las heridas no sanan, las terapias pueden costar hasta $5 mil millones
Cerca de 6,5 millones de personas en el país tienen heridas que tardan meses, y hasta años en sanar… si llegan a curarse. El costo, económico y psicológico, de estos padecimientos es astronómico.
EMS Delays In Rural Areas Leave First-Aid Gap For Bystanders To Fill
Response times for emergency medical service units are about twice as long in rural areas as in urban areas, researchers say, underscoring the need for trained lay people to provide first aid until professional help arrives.
When Wounds Won’t Heal, Therapies Spread — To The Tune Of $5 Billion
The market for wound care products booms among a growing older and diabetic patient pool, but many treatments are untested and funding for research falls short.
Despite Insurers’ Tactical Win On ACA’s Cost-Sharing Payments, Uncertainty Lingers
Court allows state attorneys general to join a pending legal challenge to keep billions in subsidies flowing to consumers and insurers, despite the Trump administration’s resistance.
Anthem’s Retreat Leaves Californians With Fewer Choices, More Worries
The nation’s second-largest insurer is shrinking its presence on Obamacare exchanges and in the broader individual market in response to prevailing uncertainty. California is just the latest — and the biggest — example.
Covered California Expects 12.5% Average Rate Rise In 2018
The figure could be higher if President Trump ends an important consumer subsidy, which he has threatened to do. The exchange also announced that Anthem Blue Cross will pull out of Covered California and the overall individual market in 16 of the 19 regions it currently serves.
